NanoVibronix Inc

NAOV
0,739
0,004 (0,54%)
Ultimo aggiornamento: 20:38:58
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202414:00BWNanoVibronix Announces PainShield Will Be Included in..
09/4/202414:30BWNanoVibronix Issues Letter to Stockholders
28/3/202413:30BWNanoVibronix Signs Agreement for Research and Development of..
26/2/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202421:45EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/1/202422:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/1/202422:30EDGAR2Form 8-K - Current report
11/12/202322:30EDGAR2Form 8-K - Current report
06/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202315:00BWNanoVibronix Featured in Your Bladder Health Magazine
05/12/202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:45EDGAR2Form 8-K - Current report
04/12/202315:00BWNanoVibronix Enters into Letter of Intent with APOGEPHA..
28/11/202315:00EDGAR2Form 8-K - Current report
28/11/202315:00BWNanoVibronix Announces Agreement for Clinical Study of..
21/11/202314:30EDGAR2Form 8-K - Current report
21/11/202314:30BWNanoVibronix Regains Nasdaq Compliance
14/11/202314:30BWNanoVibronix Issues Letter to Shareholders
13/11/202322:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202314:30EDGAR2Form 8-K - Current report
07/11/202314:30BWNanoVibronix UroShield Products Available on NHS Drug Tariff..
27/9/202314:00EDGAR2Form 8-K - Current report
27/9/202314:00BWNanoVibronix Gains Approval for Inclusion of UroShield..
22/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21/9/202316:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/9/202316:25EDGAR2Form RW - Registration Withdrawal Request
12/9/202322:15EDGAR2Form S-3 - Registration statement under Securities Act of..
06/9/202314:30EDGAR2Form 8-K - Current report
06/9/202314:30BWNanoVibronix Announces Presentation of Positive Independent..
01/9/202322:30EDGAR2Form 8-K - Current report
30/8/202320:29BWNanoVibronix Announces $5 Million Private Placement Priced..
30/8/202314:30EDGAR2Form 8-K - Current report
30/8/202314:30BWNanoVibronix Cites Positive Results from Independent Testing..
29/8/202322:05EDGAR2Form 8-K - Current report
29/8/202322:05BWNanoVibronix Responds to CMS’ Determination for PainShield
28/8/202314:30EDGAR2Form 8-K - Current report
28/8/202314:30BWNanoVibronix Applies for Inclusion of UroShield Products in..
23/8/202322:45EDGAR2Form 8-K - Current report
23/8/202314:45BWNanoVibronix Extends Distribution Agreement with Its Largest..
11/8/202323:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202323:14EDGAR2Form S-1/A - General form for registration of securities..
01/8/202322:30EDGAR2Form S-3 - Registration statement under Securities Act of..
20/7/202322:45EDGAR2Form 8-K - Current report
Apertura: 0,723 Min: 0,6775 Max: 0,7538
Chiusura: 0,735

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network